Clincosm LogoSign in Get a demo

cognitive impairments

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Cognitive Impairments Trial (Arm 1: Attention Control, Arm 2: Computerized Training (BrainHQ))

Not yet recruiting
  • Breast Cancer
  • Cognitive Impairments
  • Arm 1: Attention Control
  • Arm 2: Computerized Training (BrainHQ)
  • (no location specified)
May 31, 2023

Technology, Cognitive Impairments, Intellectual Disability Trial in Hong Kong (Tablet-based interactive games experimental group

Not yet recruiting
  • Technology
  • +2 more
  • Tablet-based interactive games experimental group intervention
  • Hong Kong, Hong Kong
  • +4 more
Apr 18, 2023

Cognitive Impairments Trial in Villaviciosa De Odón (AOT intervention)

Completed
  • Cognitive Impairments
  • AOT intervention
  • Villaviciosa De Odón, Madrid, Spain
    Cecilia Estrada Barranco
Oct 15, 2022

Mild Traumatic Brain Injury: a Longitudinal Cohort Study

Completed
  • Mild Traumatic Brain Injury
  • +3 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    May 8, 2022

    Unipolar and Bipolar Depression:Based on the THINC-it Tool

    Recruiting
    • Cognitive Impairments
      • Shanghai, Shanghai, China
        Shanghai Mental Health Center IRB
      Oct 24, 2021

      Alcohol-related Cognitive Impairments in Cirrhotic Patients

      Recruiting
      • Alcohol Dependence
      • +4 more
      • questionnaire
      • Amiens, France
        CHU Amiens
      Sep 7, 2021

      Cognitive Impairments, Stroke, Brain Injuries Trial in Linköping (Cognitive support by RemindMe)

      Completed
      • Cognitive Impairments
      • +2 more
      • Cognitive support by RemindMe
      • Linköping, Ostergotland, Sweden
        Region of Ostergotland
      Jul 13, 2020

      Multimorbidity, Cognitive Impairments Trial in Durham (Care management via videoconference, Care management via telephone calls)

      Completed
      Has Results
      • Multimorbidity
      • Cognitive Impairments
      • Care management via videoconference
      • Care management via telephone calls
      • Durham, North Carolina
        Durham VA Medical Center, Durham, NC
      Sep 12, 2019

      Cognitive Impairments, RRSO Trial in Philadelphia (lisdexamfetamine, Placebo)

      Withdrawn
      • Cognitive Impairments
      • RRSO
      • Philadelphia, Pennsylvania
        Penn Center for Women's Behavioral Wellness
      Sep 15, 2017

      Symptomatic Menopause, Cognitive Impairments Trial in Philadelphia (Lisdexamfetamine, Placebo)

      Completed
      Has Results
      • Symptomatic Menopause
      • Cognitive Impairments
      • Philadelphia, Pennsylvania
        Penn Center for Women's Behavioral Wellness
      May 25, 2017

      Cognitive Impairments, Dementia, Alzheimer Trial (Ability platform program, Usual care program)

      Completed
      • Cognitive Impairments
      • +2 more
      • Ability platform program
      • Usual care program
      • (no location specified)
      Jan 16, 2017

      Cognitive Impairments, Aging Trial in Novi Sad (Molecular Hydrogen)

      Completed
      • Cognitive Impairments
      • Aging
      • Molecular Hydrogen
      • Novi Sad, Vojvodina, Serbia
        Applied Bioenergetics Lab at Faculty of Sport and PE
      Oct 27, 2016

      Cognitive Impairments, Alzheimer Trial in Elche, Torrevieja, (Lipidic Blend 1, Lipidic Blend 2, Placebo)

      Unknown status
      • Cognitive Impairments
      • Alzheimer Disease
      • Lipidic Blend 1
      • +2 more
      • Elche, Alicante, Spain
      • +1 more
      Jun 1, 2016

      Chronic Fatigue Syndrome, Cognitive Impairments Trial in Rochester Hills (Lisdexamfetamine Dimesylate, Placebo "30, 50 or 70

      Completed
      Has Results
      • Chronic Fatigue Syndrome
      • Cognitive Impairments
      • Lisdexamfetamine Dimesylate
      • Placebo "30, 50 or 70 mg"
      • Rochester Hills, Michigan
        Rochester Center for Behavioral Medicine
      Mar 17, 2015

      Cognitive Impairments, Schizotypal Personality Disorder Trial in New York (DAR-0100A, Placebo)

      Unknown status
      • Cognitive Impairments
      • Schizotypal Personality Disorder
      • New York, New York
        Mount Sinai School of Medicine
      Jul 19, 2012

      Pergolide for Cognitive Impairment and Negative Symptoms in

      Suspended
      • Schizophrenia
      • +2 more
      • Pergolide (drug)
      • Hamamatsu, Shizuoka, Japan
        Hamamatsu University Hospital
      Sep 13, 2005